Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Key targets of hormonal treatment of prostate cancer
BJU International, 06/30/09
Vis AN et al. - In CRPC, prostate cancer cells still rely on intracellular androgens and on an active AR for growth and survival. CRPCs have gained mechanisms that enable them to use steroids from the circulation more efficiently through altered gene expression, and through a renewed and up-regulated synthesis of steroid hormone-converting enzymes. Additionally, CRPCs might synthesise AR isoforms that enable AR mediated processes independent from available androgens.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
Cancer Research, 11/03/09
Sexual Arousal by Higher- and Lower-Ranking Partner: Manifestation of a Mating Strategy
The Journal of Sexual Medicine, 11/03/09
Reduced Labial Temperature in Response to Sexual Films with Distractors among Women with Lower Sexual Desire
The Journal of Sexual Medicine, 11/03/09
Today in Endocrine...keeping you current
Receive free subspecialty "5-minute updates" via email
Timetable of effects of testosterone administration to hypogonadal men on variables of sex and mood
The Aging Male, 11/13/09
Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09
Testosterone replacement in prostate cancer survivors with hypogonadal symptoms
BJU International, 11/17/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Is statin use associated with prostate cancer aggressiveness
BJU International, 11/09/09
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
What comes after docetaxel
Der Urologe, 11/18/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Is statin use associated with prostate cancer aggressiveness
BJU International, 11/09/09
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence
Journal of Clinical Oncology, 11/02/09
Article Search
Sponsor


See Latest Articles


